A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease

June 16, 2010 updated by: Beijing YouAn Hospital
The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe hand-foot-mouth disease.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

390

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Anhui, China
        • Recruiting
        • Anhui Provincial Children's Hospital
        • Contact:
          • Biquan Chen
          • Phone Number: 13856065978
        • Sub-Investigator:
          • Biquan Chen
      • Beijing, China
        • Recruiting
        • Beijing Youan Hospital,Capital Medical University
        • Principal Investigator:
          • Xiuhui Li, MD
        • Contact:
    • Guangdong
      • Guangzhou, Guangdong, China
        • Recruiting
        • Guangzhou Women and Children Hospital
        • Contact:
          • Yi Xu
          • Phone Number: 13416427315
        • Sub-Investigator:
          • Yi Xu
    • Guangxi
      • Nanning, Guangxi, China
        • Recruiting
        • The First Affiliated Hospital of Guangxi Medical University
        • Contact:
          • Dan Wei
          • Phone Number: 13977166581
        • Sub-Investigator:
          • Dan Wei
    • Henan
      • Kaifeng, Henan, China
        • Recruiting
        • Kaifeng Municipal Children's Hospital
        • Contact:
          • Xi Zhang
          • Phone Number: 13069307700
        • Sub-Investigator:
          • Xi Zhang
    • Hunan
      • Changsha, Hunan, China
        • Recruiting
        • Hunan Provincial Children's Hospital
        • Contact:
          • Shuangjie Li
          • Phone Number: 15874162057
        • Sub-Investigator:
          • Shuangjie Li

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Clinical diagnosis of severe hand-foot-mouth disease patients according to hand-foot-mouth disease treatment guidelines 2010 issued by China's Ministry of Health
  2. not more than 24 hours of occurrence of severe symptoms
  3. age of 1-13 years
  4. Patients or their guardians agree to participate in this study and signed the informed consent form

Exclusion Criteria:

  1. Suffering from neurogenic pulmonary edema, heart or lung failure.
  2. Complicated with other serious diseases such as chronic hepatitis, congenital heart disease, acute or chronic nephritis and blood diseases, etc
  3. the history of allergies on Chinese medicine
  4. the history of mild increase of blood bilirubin hemolysis (or uric bravery former positive) phenomenon
  5. using hormonal therapy
  6. Attending other clinical studies on hand-foot-mouth disease
  7. Patients or their guardians suffering from mental illness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Experimental: Herbal concentrate-granules plus western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Experimental: Reduning Injection plus western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
incidence of complications
Time Frame: 15 days
15 days
incidence of critically ill patients
Time Frame: 15 days
15 days

Secondary Outcome Measures

Outcome Measure
Time Frame
case fatality rate
Time Frame: 15 days
15 days
time of symptom disappearance
Time Frame: 15 days
15 days
time of bringing down a fever
Time Frame: 15 days
15 days
length of stay
Time Frame: 15 days
15 days
dose and usage of hormones
Time Frame: 15 days
15 days
safety outcome(adverse effects)
Time Frame: 15 days
15 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Anticipated)

August 1, 2010

Study Registration Dates

First Submitted

June 16, 2010

First Submitted That Met QC Criteria

June 16, 2010

First Posted (Estimate)

June 17, 2010

Study Record Updates

Last Update Posted (Estimate)

June 17, 2010

Last Update Submitted That Met QC Criteria

June 16, 2010

Last Verified

May 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hand, Foot and Mouth Disease

Clinical Trials on Western therapy

3
Subscribe